FOR IMMEDIATE RELEASE 24 MARCH 2005
CHEMRING GROUP PLC
AGM STATEMENT BY THE CHAIRMAN
Ken Scobie, Chairman of Chemring Group PLC ('Chemring' or 'the Company'), made
the following statement at the Company's Annual General Meeting today: 'I am
delighted to report that trading remains buoyant for the Group's
countermeasures business, particularly with the Department of Defense in the
United States. Alloy Surfaces' second plant and technology centre is now
operational, and the official opening will be held on 11 April.
Chemring sees continuing growth in decoy sales for several years. The Company
does not believe that new technologies, such as lasers which are more expensive
and technologically challenging, will have any measurable impact on its decoy
sales for at least ten years. In many operational scenarios, decoys and lasers
complement each other, and currently combinations of decoys are effectively
protecting military aircraft from various MANPAD threats.
The Company continues to explore a number of acquisition opportunities in areas
which are geographically and operationally complementary to its existing
businesses.'
For further information:
Ken Scobie Chairman, Chemring Group PLC 01489 881880
David Evans Chief Executive, Chemring Group PLC 01489 881880
Jonathan Rooper Cardew Group 0207 930 0777
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.